Bristol-Myers Squibb buy Guggenheim
Start price
23.12.25
/
50%
€46.50
Target price
23.12.26
-
Performance (%)
3.55%
Price
15:42
€48.15
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 3.55%. This prediction currently runs until 23.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | 4.145% |
| iShares Core DAX® | 2.659% |
| iShares Nasdaq 100 | 0.916% |
| iShares Nikkei 225® | 2.426% |
| iShares S&P 500 | 1.230% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat

